GSK to Receive $320 Million as BioNTech and Pfizer Settle mRNA Patent Dispute with CureVac
One of the biggest developments in the ongoing GSK and CureVac patent dispute has arrived—GSK will receive $320 million following a settlement between BioNTech…
Read more